But there are tradeoffs, as mandating that plans integrate the amount spent on TrumpRx drugs could lead to higher premiums as payers try to offset costs
Stopping semaglutide itself does not cause dangerous withdrawal symptoms
Novo Nordisk says the US FDA has approved a once daily pill version of Wegovy, described as the first approved pill of its kind The company said trials showed average weight loss of 16.6%, with about a third of roughly 1,300 participants losing 20% or more Novo Nordisk expects a US launch in early January 2026, with investors pushing shares up sharply after the announcement amid strong competition in the weight loss market US regulators have approved an oral version of Wegovy for chronic weight management, giving Novo Nordisk the first daily pill in this drug class cleared for obesity treatment, according to the company and US media reports
Recognized, focused, and built for modern metabolic research
If you want to assess dysbiosis more directly, our Lab Gut Microbiome Test looks at microbiome balance, digestion markers, and inflammation indicators to support a personalised plan
Jody Dushay, an endocrinologist and obesity expert at Harvard Medical School, said many of her patients who have switched from injections to the Wegovy pill have complained they dont lose that much weight
